Associated Papers
Relevance of Next-Generation Sequencing in the Diagnosis of Thalassemia and Hemoglobinopathies: The Experience of Four Italian Diagnostic Hubs.
Selvatici R et al.
Genes, 2024
Detection of 13 Novel Variants and Investigation of Mutation Distribution by Next Generation Sequencing in Hemoglobinopathies: A Single Center Experience.
Ozalp O et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion, 2024
HBB mutations and HbA2 level: Escaping the carrier screening programs.
Sharifi A et al.
Clinical Case Reports, 2021
Genotype-phenotype correlation of HbH disease in northern Iraq.
Shamoon RP et al.
Bmc Medical Genetics, 2020
Hemoglobinopathies in Iran: An Updated Review.
Nasiri A et al.
International Journal of Hematology-oncology and Stem Cell Research, 2020
Severe α-Thalassemia Due to Compound Heterozygosity for Hb Adana (α59 Gly>Asp) (HBA1: c.179G > A) and Codon 127 (A > T) (HBA2: c.382A > T) in an Iranian Family.
Azimi A et al.
Hemoglobin, 2020
Genotype-phenotype association analysis identifies the role of α globin genes in modulating disease severity of β thalassaemia intermedia in Sri Lanka.
Perera S et al.
Scientific Reports, 2019
Molecular characterization of β-thalassemia intermedia in the West Bank, Palestine.
Faraon R et al.
Bmc Hematology, 2019
Prevalence and Genetic Analysis of α- and β-Thalassemia and Sickle Cell Anemia in Southwest Iran.
Nezhad FH et al.
Journal of Epidemiology and Global Health, 2018
Frequency of α-Globin Gene Triplications and Coinheritance with β-Globin Gene Mutations in the Iranian Population.
Abedini SS et al.
Hemoglobin, 2018
β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint.
De Sanctis V et al.
Mediterranean Journal of Hematology and Infectious Diseases, 2017
Molecular Characterization of β-Thalassemia in the Czech and Slovak Populations: Mediterranean, Asian and Unique Mutations.
Divoka M et al.
Hemoglobin, 2016
Haemoglobin Variant Screening in Jamaica: Meeting Student's Request.
Mason K et al.
British Journal of Haematology, 2016
Identification of Mutations Causing Aberrant Termination and Deficient Splice Donor Site on the HBA1 Gene.
Farashi S et al.
Hemoglobin, 2016
Molecular Basis of β-Thalassemia Intermedia in Erbil Province of Iraqi Kurdistan.
Shamoon RP et al.
Hemoglobin, 2015
Sistani population: a different spectrum of β-thalassemia mutations from other ethnic groups of Iran.
Miri-Moghaddam E et al.
Hemoglobin, 2013
Beta-Thalassemia in Iran: new insight into the role of genetic admixture and migration.
Rezaee AR et al.
Thescientificworldjournal, 2012
Molecular characterization of β-thalassemia intermedia: a report from Iran.
Arab A et al.
Molecular Biology Reports, 2011
Hb S-β-thalassemia: molecular, hematological and clinical comparisons.
Serjeant GR et al.
Hemoglobin, 2011
Spectrum of β-thalassemia mutations in the eastern province of Saudi Arabia.
Al-Sultan A et al.
Hemoglobin, 2011
Molecular heterogeneity of beta-thalassemia in Algeria: how to face up to a major health problem.
Boudrahem-Addour N et al.
Hemoglobin, 2009
Molecular basis of thalassemia intermedia in Iran.
Akbari MT et al.
Hemoglobin, 2008
Rapid detection of beta-Thalassemia alleles in Egypt using naturally or amplified created restriction sites and direct sequencing: a step in disease control.
Hussein G et al.
Hemoglobin, 2007
Diagnosis of the haemoglobinopathies.
Trent RJ
The Clinical Biochemist. Reviews, 2006
Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.
Yavarian M et al.
Haematologica, 2004
The beta-thalassemia mutation/haplotype distribution in the moroccan population.
Lemsaddek W et al.
Hemoglobin, 2004
Beta-thalassemia intermedia from southern Iran: IVS-II-1 (G-->A) is the prevalent thalassemia intermedia allele.
Karimi M et al.
Hemoglobin, 2002